CLINICAL_TRIALS
trial_result
· 2017-12-14
Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins [Phase 3]
Summary
A Phase 3 randomized trial evaluating bococizumab in statin-intolerant patients with hyperlipidemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2017-12-14